Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
34.74
-1.05 (-2.92%)
Aug 11, 2026, 11:37 AM EDT - Market open
Roivant Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7.53 | 8.26 | 29.05 | 32.71 | 61.28 | 55.29 | |
Revenue Growth | -67.58% | -71.57% | -11.19% | -46.62% | 10.84% | 132.34% |
Cost of Revenue | 1.42 | 1.29 | 0.91 | 1.6 | 13.13 | 8.97 |
Gross Profit | -1.42 | 6.98 | 28.14 | 31.11 | 48.15 | 46.32 |
Selling, General & Admin | 641.97 | 610.47 | 591.41 | 416.13 | 600.51 | 775.03 |
Research & Development | 730.91 | 681.81 | 550.41 | 466.36 | 622.96 | 622.93 |
Other Operating Expenses | - | -770.24 | -110.39 | -5,348 | - | - |
Total Operating Expenses | 1,373 | 522.04 | 1,031 | -4,466 | 1,223 | 1,398 |
Operating Income | -596.14 | -515.07 | -1,003 | 4,497 | -1,175 | -1,352 |
Interest Income | 166.71 | 178.11 | 258.38 | 146.43 | 32.18 | 0.37 |
Interest Expense | - | - | - | - | -27.97 | -7.04 |
Other Non-Operating Income (Expense) | 128.52 | 72.38 | 63.33 | -75.6 | -53.73 | 434.57 |
Total Non-Operating Income (Expense) | 295.23 | 250.49 | 321.7 | 70.82 | -49.52 | 427.9 |
Pretax Income | -289.88 | -264.58 | -681.59 | 4,568 | -1,225 | -923.75 |
Provision for Income Taxes | 124.72 | 133.33 | 48.17 | 21.5 | 5.19 | 0.37 |
Net Income | -414.6 | -397.91 | -729.76 | 4,546 | -1,230 | -924.12 |
Minority Interest in Earnings | -148.35 | -98.14 | -184.75 | -117.72 | -106.43 | -78.85 |
Earnings From Discontinued Operations | - | - | 373.03 | -315.15 | 114.56 | - |
Net Income to Common | -266.25 | -299.77 | -171.98 | 4,349 | -1,009 | -845.26 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 700 | 694 | 725 | 783 | 713 | 670 |
Shares Outstanding (Diluted) | 728 | 694 | 725 | 831 | 713 | 670 |
Shares Change | 2.29% | -4.35% | -12.71% | 16.59% | 6.43% | 6.30% |
EPS (Basic) | -0.38 | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 |
EPS (Diluted) | -0.53 | -0.54 | -0.24 | 5.23 | -1.42 | -1.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -821.06 | -758.56 | -844.05 | -766.65 | -856.08 | -695.17 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.13 | -1.09 | -1.16 | -0.92 | -1.20 | -1.04 |
Gross Margin | -18.79% | 84.44% | 96.86% | 95.11% | 78.58% | 83.78% |
Operating Margin | -7914.75% | -6235.69% | -3453.32% | 13746.90% | -1917.95% | -2444.82% |
Profit Margin | -5504.54% | -4817.28% | -2511.84% | 13897.70% | -2007.22% | -1671.52% |
FCF Margin | -10901.00% | -9183.51% | -2905.21% | -2343.56% | -1397.00% | -1257.40% |
EBITDA | -593.29 | -511.72 | -989.22 | 4,519 | -1,156 | -1,346 |
EBITDA Margin | -7876.91% | -6195.16% | -3404.89% | 13814.30% | -1887.18% | -2434.09% |
EBIT | -596.14 | -515.07 | -1,003 | 4,497 | -1,175 | -1,352 |
EBIT Margin | -7914.75% | -6235.69% | -3453.32% | 13746.90% | -1917.95% | -2444.82% |
Effective Tax Rate | -43.03% | -50.39% | -7.07% | 0.47% | -0.42% | -0.04% |